Gross Profit On Sales 変化する 日付
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Chugai Pharma JPY 179.64B 3.89B 2023-09
Daiichi Sankyo JPY 280.77B 23.61B 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Incyte USD 949.29M 84.66M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Novavax USD 88.06M 281.09M 2023-09
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



BioCryst Pharmaceuticals 売上総利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2024.